Share tips 2025: this week’s top picks

Share tips 2025: MoneyWeek’s roundup of the top picks this week – here’s what the experts think you should buy

Stock market share tips graph trading analysis
(Image credit: Getty Images)

If you’ve been keeping a close eye on share tips 2025, then don’t miss this weekly round-up of the top stocks to consider for your portfolio.

The MoneyWeek share tips 2025 guide pulls together some of the best UK stocks from some of the top share tipsters around.

As well as the UK financial pages, we look at publications across the pond for investors who want to diversify their holdings internationally.

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free
https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Sign up

We look at where to invest in 2025 – from big tech stocks and European equities to finding value in the FTSE 100.

This list is updated weekly on a Friday.

Share tips 2025: top picks of the week

Five to buy

1. Auto Trader (LSE: AUTO)
The Telegraph
Auto Trader is worthy of a premium valuation because it is a “very high-quality company” with a record of earnings growth. The online marketplace for vehicles is more than ten times the size of its nearest competitor, and expected falls in inflation and interest rates bode well. The company has a “strong” balance sheet and can deliver further attractive returns. 778p

2. Experian (LSE: EXPN)
The Times
Experian is a “high-quality stock with [a] consistent record of growth”. The credit data and analytics company benefits from an extremely high barrier to entry for rivals and boasts Nick Train as an investor. Experian is targeting organic growth of 6%-8% in 2025 and has raised its operating-margin growth forecast too. The company trades at a discount to rivals Relx and Equifax. “For a reliable, quality compounder, the price tag on the shares looks worth biting the bullet.” 3,939p

3. Bytes Technology (LSE: BYIT)
This is Money
Bytes Technology’s shares are “undervalued and should rebound through 2025 and beyond”. The £1.1 billion software, security and cloud services provider works with several suppliers and is Britain’s number-one reseller of Microsoft’s products, with customers including the police and local authorities. It has the potential to expand its market share and a history of paying dividends. Analysts expect profits to increase. “With a strong... record and a reputation for delivering on its promises”, Bytes “should prove resilient” in uncertain times. 448p

4. Hargreaves Services (LSE: HSP)
Shares
Hargreaves Services’s shares are trading at a ten-year high, but there is “more to come”. The environmental services, property, and materials group is an “asset-backed income play” with steady revenue from the services business, periodic revenue from land disposals, and regular dividends from its German subsidiary. Hargreaves is moving to a capital-light model and plans to return surplus capital to shareholders. With a 6% yield, investors “can afford to sit and wait for the cash to roll in”. 620p

5. AstraZeneca (LSE: AZN)
Investors’ Chronicle
AstraZeneca’s full-year results confirmed double-digit growth rates for some of its key products. The pharma giant’s underlying margins are starting to expand again, and it expects low double-digit core earnings growth for 2025. Its oncology portfolio should maintain high returns. AstraZeneca seems to have set aside legal problems in China, and with nine phase-III clinical trials last year and a further seven expected this year, the company is confident about its pipeline. AstraZeneca is aiming to deliver $80 billion in total revenue by 2030. The shares are not cheap compared with peers, but “you can... feel the quality”. 11,844p

One to sell

1. WizzAir (LSE: WIZZ)
The Times
WizzAir has lost over two-fifths of its market value since last January as it grapples with higher costs, trouble with engines that have grounded around 40 of its aeroplanes, and production problems at Airbus, which have slowed delivery rates of its new aircraft. Third-quarter passenger numbers and revenue increased, but costs grew owing to rescheduled operations and changing staff shifts. The budget carrier lowered full-year profit expectations by at least €100 million. Wizz’s higher debt could leave it “more exposed” in the event of an industry downturn. “Avoid” Wizz: its “lowly valuation reflects high risk.” 1,669p

The rest...

1. Dunelm (LSE: DNLM)
Investors’ Chronicle
Dunelm’s first-half pre-tax profit was flat and is set to rise only 2% to £209 million in the year to July. The homeware retailer is in a “tough environment”, but is taking market share and has strong free cash flow, which allowed it to raise its interim dividend and repeat last year’s special dividend. However, demand remains “subdued,” and controlling costs will be “tougher” in the second half as employment costs rise. Although the stock seems “cheap”, “we stick with our hold call” (1,015p).

2. GlaxoSmithKline (LSE: GSK)
The Telegraph
The 2025 outlook for GlaxoSmithKline (GSK) is a “little better than expected”, with dividend growth and a £2 billion buyback. GSK offers a 4% dividend yield and a price/ earnings ratio of 11, a discount to global peers. GSK seems to be through the worst when it comes to US lawsuits regarding its heartburn drug Zantac, but concerns remain about the Trump administration’s impact on the pharma industry, so its speciality medicines must continue to perform, and the drug-development pipeline must deliver. GSK’s “lowly” valuation implies that expectations on this front are “fairly low”, but “this is where the upside potential lies”. Buy (1,465p).

3. London Stock Exchange Group (LSE: LSEG)
The Times
The London Stock Exchange Group (LSEG) has become a top data provider thanks to its takeover of Refinitiv. The data unit will contribute 20% of topline growth over the next two years. LSEG generates recurring revenue with subscriptions, has a high level of client retention, and has a partnership with Microsoft. The shares trade at a discount to its US peers. LSEG is a “high-quality, defensive investment with impressive growth potential”. Buy (11,690p).


This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.

Kalpana Fitzpatrick

Kalpana is an award-winning journalist with extensive experience in financial journalism. She is also the author of Invest Now: The Simple Guide to Boosting Your Finances (Heligo) and children's money book Get to Know Money (DK Books).

Her work includes writing for a number of media outlets, from national papers, magazines to books.

She has written for national papers and well-known women’s lifestyle and luxury titles. She was finance editor for Cosmopolitan, Good Housekeeping, Red and Prima.

She started her career at the Financial Times group, covering pensions and investments.

As a money expert, Kalpana is a regular guest on TV and radio – appearances include BBC One’s Morning Live, ITV’s Eat Well, Save Well, Sky News and more. She was also the resident money expert for the BBC Money 101 podcast .

Kalpana writes a monthly money column for Ideal Home and a weekly one for Woman magazine, alongside a monthly 'Ask Kalpana' column for Woman magazine.

Kalpana also often speaks at events. She is passionate about helping people be better with their money; her particular passion is to educate more people about getting started with investing the right way and promoting financial education.